Use of Multi-Site Radiation Therapy for Systemic Disease Control-Reference-Cited by-同舟云学术

Use of Multi-Site Radiation Therapy for Systemic Disease Control

Published:2021-02 Issue:2 Volume:109 Page:352-364
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Patel Roshal R.,Verma Vivek,Barsoumian Hampartsoum B.,Ning Matthew S.,Chun Stephen G.,Tang Chad,Chang Joe Y.,Lee Percy P.,Gandhi Saumil,Balter Peter,Dunn Joe Dan,Chen Dawei,Puebla-Osorio Nahum,Cortez Maria Angelica,Welsh James W.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference124 articles.

1. Radiotherapy in the age of cancer immunology: Current concepts and future developments;Loi;Crit Rev Oncol Hematol,2017

2. Radiation and anti-cancer vaccines: A winning combination;Cadena;Vaccines (Basel),2018

3. Recent advances in radiation oncology;Garibaldi;Ecancermedicalscience,2017

4. Phase I trial of pembrolizumab and radiation therapy after induction chemotherapy for extensive-stage small cell lung cancer;Welsh;J Thorac Oncol,2020

5. Phase II Trial of ipilimumab with stereotactic radiation therapy for metastatic disease: outcomes, toxicities, and low-dose radiation-related abscopal responses;Welsh;Cancer Immunol Res,2019

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locoregional therapies combined with immune checkpoint inhibitors for liver metastases;Cancer Cell International;2024-08-31

2. The future of cancer treatment: combining radiotherapy with immunotherapy;Frontiers in Molecular Biosciences;2024-07-09

3. Is Single-Site Radiation Therapy Enough to Augment the Immune System and Enhance Immunotherapy for Metastatic Disease?;Seminars in Radiation Oncology;2024-07

4. Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis;Heliyon;2024-03

5. Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report;Frontiers in Immunology;2024-02-01